BackgroundCheck.run
Search For

Rui Li, 53South Lynnfield, MA

Rui Li Phones & Addresses

Lynnfield, MA   

Round Rock, TX   

Hopkinton, MA   

1042 Main St, Malden, MA 02148   

Waco, TX   

164 Adams St, Malden, MA 02148   

Work

Company: Total health acupuncture Jun 2006 Position: Office administrator

Education

School / High School: Boston University- Boston, MA May 2014 Specialities: Bachelor of Arts in International Relations and East Asian Studies

Skills

Chinese (Native fluency) • Japanese (Intermediate) • Spanish (Intermediate) • Research and Analysis • Translation • Microsoft Office • Adobe Photoshop • HTML

Mentions for Rui Li

Rui Li resumes & CV records

Resumes

Rui Li Photo 31

Rui Li - West Springfield, MA

Work:
Total Health Acupuncture Jun 2006 to 2000
Office Administrator
Control Risks Group Sep 2013 to Dec 2013
Market Research Intern
China Law Info Co., Ltd Jun 2011 to Aug 2011
Media Translator
Education:
Boston University - Boston, MA May 2014
Bachelor of Arts in International Relations and East Asian Studies
Fudan University 2013
Chinese Language and Literature, Chinese History, and International Business Studies
International Christian University - Tokyo, Japan 2012
Japanese Language, Japanese Cultural Studies
Skills:
Chinese (Native fluency), Japanese (Intermediate), Spanish (Intermediate), Research and Analysis, Translation, Microsoft Office, Adobe Photoshop, HTML

Publications & IP owners

Us Patents

High Affinity Integrin Polypeptides And Uses Thereof

US Patent:
7064180, Jun 20, 2006
Filed:
Jan 11, 2001
Appl. No.:
09/758493
Inventors:
M. Amin Arnaout - Chestnut Hill MA, US
Rui Li - Medford MA, US
Jian-Ping Xiong - Quincy MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
A61K 38/04
US Classification:
530324
Abstract:
Polypeptides comprising all or part of a variant integrin α subunit A domain or a variant integrin β subunit A-like domain are described. In solution or in membrane-associated form, the A domain or the A-like domain of the polypeptides of the invention exists predominantly in a high affinity conformation. In the polypeptides of the invention, referred to as variant integrin polypeptides, a crucial isoleucine residue (described in greater detail below) is absent. The isoleucine can be either deleted or replaced with different amino acids residue, preferably a smaller or less hydrophobic amino acid residue, e. g. , alanine or glycine. Because the variant integrin polypeptides of the invention exist in solution or in membrane-associated form predominantly in a high affinity conformation, they are useful in screening assays for the identification of molecules that bind to (and/or mediate the activity of) an integrin. They are also useful for generating antibodies, e. g. , monoclonal antibodies, which bind to the high affinity form of an integrin.

High Affinity Integrin Polypeptides And Uses Thereof

US Patent:
7153944, Dec 26, 2006
Filed:
Mar 13, 2001
Appl. No.:
09/805354
Inventors:
M. Amin Arnaout - Chestnut Hill MA, US
Rui Li - Medford MA, US
Jian-Ping Xiong - Quincy MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
C07K 1/107
G01N 33/53
US Classification:
530402, 435 71
Abstract:
Polypeptides comprising all or part of a variant integrin α subunit A domain or a variant integrin β subunit A-like domain are described. In solution or in membrane-associated form, the A domain or the A-like domain of the polypeptides of the invention exists predominantly in a high affinity conformation. In the polypeptides of the invention, referred to as variant integrin polypeptides, a crucial isoleucine residue (described in greater detail below) is absent. The isoleucine can be either deleted or replaced with different amino acids residue, preferably a smaller or less hydrophobic amino acid residue, e. g. , alanine or glycine. Because the variant integrin polypeptides of the invention exist in solution or in membrane-associated form predominantly in a high affinity conformation, they are useful in screening assays for the identification of molecules that bind to (and/or mediate the activity of) an integrin. They are also useful for generating antibodies, e. g. , monoclonal antibodies, which bind to the high affinity form of an integrin.

Variant Integrin Polypeptides And Uses Thereof

US Patent:
7323552, Jan 29, 2008
Filed:
May 10, 2002
Appl. No.:
10/144259
Inventors:
M. Amin Arnaout - Chestnut Hill MA, US
Rui Li - Medford MA, US
Jian-Ping Xiong - Quincy MA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
C07K 1/107
A61K 38/04
G01N 33/53
US Classification:
530402, 435 71, 530324
Abstract:
Polypeptides comprising all or part of a variant integrin α subunit A domain and its flanking region are described. In solution or in membrane-associated form, the A domain polypeptides of the invention exists predominantly in a high affinity conformation. In the polypeptides of the invention, referred to as variant integrin polypeptides, a crucial isoleucine or glutamic acid residue is altered. For example, the glutamic acid can be either deleted or replaced with different amino acids residue, e. g. , glutamine, aspartic acid, or alanine The variant integrin polypeptides of the invention selectively impair binding of activation-dependent ligands, but not independent ligands. They are useful in screening assays for the identification of molecules that enhance binding of variant polypeptides with impaired binding. In addition, they are useful in distinguishing between activation-dependent ligands and activation-independent ligands. They are also useful for generating antibodies, e. g.

Image Segmentation Using Spatial Random Walks

US Patent:
8218869, Jul 10, 2012
Filed:
Mar 29, 2009
Appl. No.:
12/413593
Inventors:
Fatih M. Porikli - Watertown MA, US
Rui Li - Brookline MA, US
Assignee:
Mitsubishi Electric Research Laboratories, Inc. - Cambridge MA
International Classification:
G06K 9/34
US Classification:
382173
Abstract:
The embodiments of the invention describe a method for segmenting an image. We perform an initial segmentation of the image to produce a previous segmented region and segment iteratively the image using a spatial random walk based on a shape prior of the previous segmented region to produce a next segmented region. We compare the next segmented region with the previous segmented region, and repeat the segmenting and the comparing until the previous and next segmented regions converge. After that, we select the next segmented region as a final segmented region.

Variant Integrin Polypeptides And Uses Thereof

US Patent:
2009002, Jan 22, 2009
Filed:
Jan 28, 2008
Appl. No.:
12/021074
Inventors:
M. Amin Arnaout - Chestnut Hill MA, US
Rui Li - Medford MA, US
Jian-Ping Xiong - Quincy MA, US
International Classification:
G01N 33/566
C07K 16/18
US Classification:
436501, 5303879
Abstract:
Polypeptides comprising all or part of a variant integrin α subunit A domain and its flanking region are described. In solution or in membrane-associated form, the A domain polypeptides of the invention exists predominantly in a high affinity conformation. In the polypeptides of the invention, referred to as variant integrin polypeptides, a crucial isoleucine or glutamic acid residue is altered. For example, the glutamic acid can be either deleted or replaced with different amino acids residue, e.g., glutamine, aspartic acid, or alanine The variant integrin polypeptides of the invention selectively impair binding of activation-dependent ligands, but not independent ligands. They are useful in screening assays for the identification of molecules that enhance binding of variant polypeptides with impaired binding. In addition, they are useful in distinguishing between activation-dependent ligands and activation-independent ligands. They are also useful for generating antibodies, e.g., monoclonal antibodies, which bind to the impaired form of an integrin. Some such antibodies recognize an epitope that is either not present or not accessible on an integrin that is in the high affinity conformation. The variant integrin polypeptides of the invention can be derived from any integrin α subunit that could be used therapeutically.

Voltage Droop Control

US Patent:
2018004, Feb 15, 2018
Filed:
Oct 23, 2017
Appl. No.:
15/791226
Inventors:
- San Diego CA, US
Daniel Stasiak - Austin TX, US
Martin Pierre Saint-Laurent - Austin TX, US
Rui Li - San Diego CA, US
Bin Liang - San Diego CA, US
Sei Seung Yoon - San Diego CA, US
Chulmin Jung - San Diego CA, US
International Classification:
G05F 1/10
G06F 1/32
H02M 1/32
Abstract:
A computer-readable storage medium for controlling voltage droop storing instructions that, when executed by a processor, cause a device to perform operations including receiving a first voltage to a first input of a first component of a device. The first voltage corresponding to a first logical value causes a first internal power supply of the first component to be charged using an external power supply. The operations further include providing a second voltage to a second input of a second component of the device in response to a first voltage level of the first internal power supply satisfying a second voltage level. The second voltage corresponding to the first logical value causes a second internal power supply of the second component of the device to be charged using the external power supply.

Voltage Droop Control

US Patent:
2016029, Oct 13, 2016
Filed:
Apr 10, 2015
Appl. No.:
14/684128
Inventors:
- San Diego CA, US
Daniel Stasiak - Austin TX, US
Martin Pierre Saint-Laurent - Austin TX, US
Rui Li - San Diego CA, US
Bin Liang - San Diego CA, US
Sei Seung Yoon - San Diego CA, US
Chulmin Jung - San Diego CA, US
International Classification:
G05F 1/10
Abstract:
Voltage droop control is disclosed. A device includes a first component coupled to an external power supply and a second component coupled to the external power supply. The first component includes a first input configured to receive a first voltage, a first internal power supply configured to be charged by the external power supply in response to the first voltage corresponding to a first logical value, and a voltage droop controller configured to output a second voltage via a first output. The second voltage corresponds to the first logical value in response to a first voltage level of the first internal power supply satisfying a second voltage level. The second component includes a second input configured to receive the second voltage from the first output.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.